Epitomics Inc.
The story of the Rabbit MonoClonal Antibody Company
86 views
00:09:54 - Uploaded by Song Essinova, LLC on May 9, 2009
With proven success of the Rabbit MonoClonal Antibody technology in research and diagnostics, Epitomics is poised to brave the development of therapeutics.
Tags: MonoClonal, antibody, reagent, diagnostics, therapeutics, China
RELATED
COMMENTS
There are 1 comments. You must be logged in to comment.
-
Li Yan says:
June 8, 2009
Discovery & Development
-
Emerging Trends and Opportunities in the BioPharmaceutical Industry in China and the US
-
Strategic Alliances with Partners in China: Apexigen's Experience
-
Balancing Aggressiveness and Conservatism
-
US-China Anti-Cancer Association Scholar Award for Cancer Research
-
Expanding Access to Patients in Need Around the World
-
BioPacific 2010 - Drug Discovery and Development in Changing Times
-
China Drug Discovery Landscape
-
China Drug Discovery Landscape
-
Optivia Webinar - Transporter-Enzyme and Transporter-Transporter Interplay in Predicting Drug Absorption and Disposition
-
Location Determines PKC Specificity
-
KAI Selective PKC Inhibitors
-
KAI Selective PKC Activators
-
Epitomics Inc.
